Schizophrenia Clinical Trial
Official title:
Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia
Social cognition impairments was highlighted for persons suffering with schizophrenia by
numerous studies. The use of treatment programs intended to treat specifically these
deficits through procedures of cognitive remediation, will allow decreasing their impact on
everyday life by improving abilities to understand and interact with others. Such tools
could allow also profits in terms of reduction of positive and negative of schizophrenia.
The Gaïa program is intended to improve the perception of the facial affects which is one of
social cognition processes impaired in schizophrenia.
Methods:
This is a multicenter, randomized, controlled study comparing people aged 18 to 45 years
with a diagnostic of schizophrenia according to the Diagnostic and Statistical manuel of
Mental disorders, 4th edition (DSM-IV-TR).
The GAÏA program will be compared to an already validated neurocognitive remediation
program, training attentional processes (RECOS).
100 patients will be randomized as follows: Arm 1, experimental: Gaïa (20h with therapist,
computer assisted method) Arm 2, control: RECOS (20h with therapist, computer assisted
method)
Condition: Schizophrenia Intervention: Behavioural: computer assisted cognitive remediation
Hypothesis:
A targeted cognitive remediation will more increased abilities in facial affects recognition
processes than a non specific, attentional cognitive remediation.
Primary outcome measures:
- Change from baseline in performances in the Facial Emotion Recognition Task (TREF) after
10 weeks and 20 session of treatment.
Secondary outcome measures
- Change from baseline in clinical, psychosocial, social cognition and neurocognitive
measures, after 10 weeks and 20 session of treatment and at 6 months follow-up.
- Change from baseline in performances in the Facial Emotion Recognition Task (TREF)
after treatment and 6 months follow-up.
Purpose:
Rationale:
Social cognition impairments was highlighted for persons suffering with schizophrenia by
numerous studies. The use of treatment programs intended to treat specifically these
deficits through procedures of cognitive remediation, will allow decreasing their impact on
everyday life by improving abilities to understand and interact with others. Such tools
could allow also profits in terms of reduction of positive and negative of schizophrenia.
The Gaïa program is intended to improve the perception of the facial affects which is one of
social cognition processes impaired in schizophrenia.
Methods:
This is a multicenter, randomized, controlled study comparing people aged 18 to 45 years
with a diagnostic of schizophrenia according to the DSM-IV-TR.
The Gaïa program will be compared to an already validated neurocognitive remediation
program, training attentional processes (RECOS).
100 patients will be randomized as follows:
1. Arm 1,Experimental: Gaïa (20h with therapist, computer assisted method)
- 10 week-treatment, with 2 sessions of 1 hour per week, and 1 homework exercise
without therapist per week.Individual therapy.
- Gaïa exercises were designed by B. Gaudelus and tutoractiv' company, for specific
use in schizophrenia. It includes computer based and paper & pen, photos and role
games exercises targeting the recognition of facial emotions.
- Computer based exercises have 5 increasing difficulty levels.
- Each participant practices all the modules of Gaïa.
2. Arm 2, control: RECOS (20h with therapist, computer assisted method)
- 10 week-treatment, with 2 sessions of 1 hour per week and 1 homework exercise
without therapist per week.Individual therapy.
- RECOS (Cognitive Remediation for Schizophrenia) exercises were designed by
Scientific Brain Training (SBT) company and P. Vianin in year 2007 for specific
use in schizophrenia.
- It includes computer based and paper & pen exercises.
- Only the RECOS attentional function module is used in the study (5 modules
available in the program) with gradual difficulty in 10 levels
Condition: Schizophrenia Intervention: Behavioural: computer assisted cognitive remediation
Study type: interventional
Study design:
- Allocation: randomized
- Endpoint classification: efficacy study
- Intervention model: parallel assignment
- Masking: Single Blind (outcomes assessor)
- Primary purpose: treatment
Official title:
Efficacy study of GAÏA program; cognitive remediation of facial affects process in
schizophrenia
Hypothesis:
A targeted cognitive remediation will more increased abilities in facial affects recognition
processes than a non specific, attentional cognitive remediation.
Primary outcome measures:
- Change from baseline in performances in the Facial Emotion Recognition Task (TREF) after
10 weeks and 20 session of treatment.
Secondary outcome measures
- Change from baseline in clinical and psychosocial measures, including symptoms,
Delusional ideas, self esteem, insight and functional outcome after 10 weeks and 20
session of treatment and at 6 months follow-up.
- Change from baseline in social cognition measures, including Theory of Mind,attribution
style, emotional conciousness and empathy processes after 10 weeks and 20 session of
treatment and at 6 months follow-up
- Change from baseline in neurocognitive functioning measures, including attentional,
working memory, processing speed, perceptive and executive functions processes after 10
weeks and 20 session of treatment and at 6 months follow-up.
- Change from baseline in performances in the Facial Emotion Recognition Task (TREF)
after treatment and 6 months follow-up.
1. Scales for clinical and psychosocial functioning measurement:
- Positive and negative symptoms scale (PANSS)
- Peters and al. Delusions Inventory 21 items (PDI21)
- Birchwood insight scale
- Self-Esteem Rating Scale (SERS)
- Social Autonomy Scale (EAS)
2. Tasks for social cognitive measurement
- Hinting task - Theory of mind
- Intentional Reading in Situation - Theory of mind - (LIS-V)
- Eyes Test - Theory of mind
- Ambiguous Intentions Hostility Questionary - Attribution style - (AIHQ)
- Levels of Emotional Awareness Scale (LEAS)
- Questionnaire of Cognitive and Affective Empathy (QCAE)
3. Tasks for neurocognitive functioning measurement
- Attentional functions: D2 test ; Attentional Testbattery (TAP)
- Executive functions: Trail making test (TMT); Search keys score - Behavioural
Assessment of Dysexecutive functions (BADS); Rey figure
- Working memory: memory span ; Corsi blocs ; Brief Visual Memory Test- Revised (BVMT-R)
processing speed: Wechsler Adult Intelligence Scale IV - Code and Symbol score (WAIS
IV) perceptive functions: HOOPER Visual Organization Test (VOT)
Eligibility
- Ages Eligible for Study: 18 years to 45 years
- Genders Eligible for Study: Both
- Accepts Healthy volunteers: No
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |